Kévin Hardonnière

Dr. Kévin Hardonnière

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KHKévin Hardonnière
Kévin Hardonnière
ESElise Saunier
Elise Saunier
ALAnthony Lemarié
Anthony Lemarié
MFMorgane Fernier
Morgane Fernier
IGIsabelle Gallais
Isabelle Gallais
DLDominique Lagadic-Gossmann
Dominique Lagadic-Gossmann
Cancer cells display alterations in many cellular processes. One core hallmark of cancer is the Warburg effect which is a glycolytic reprogramming that allows cells to survive and proliferate. Although the contributions of environmental contaminants to cancer development are widely accepted, the underlying mechanisms have to be clarified. Benzo[a]pyrene (B[a]P), the prototype of polycyclic aromatic hydrocarbons, exhibits genotoxic and carcinogenic effects and it is a human carcinogen according to the International Agency for Research on Cancer. In addition to triggering apoptotic signals, B[a]P may induce survival signals, both of which are likely to be involved in cancer promotion. We previously suggested that B[a]P-induced mitochondrial dysfunctions, especially membrane hyperpolarization, might trigger cell survival signaling in rat hepatic epithelial F258 cells. Here, we further characterized these dysfunctions by focusing on energy metabolism. We found that B[a]P promoted a metabolic reprogramming. Cell respiration decreased and lactate production increased. These changes were associated with alterations in the tricarboxylic acid cycle which likely involve a dysfunction of the mitochondrial complex II. The glycolytic shift relied on activation of the Na+/H+ exchanger 1 (NHE1) and appeared to be a key feature in B[a]P-induced cell survival related to changes in cell phenotype (epithelial-to-mesenchymal transition and cell migration).

1 March 2025 in BioFactors
Verified
Journal Article
Open access
SSSara Salman
Sara Salman
VPVirginie Paulet
Virginie Paulet
KHKévin Hardonnière
Kévin Hardonnière
SKSaadia Kerdine-Römer
Saadia Kerdine-Römer
The skin is the body's largest organ and performs several vital functions, such as controlling the movement of essential substances while protecting against external threats. Although mainly composed of keratinocytes (KCs), the skin also contains a complex network of immune cells that play a critical role in host defense and maintaining skin homeostasis. KCs proliferate in the basal layer of the epidermis and undergo differentiation, altering their functional and phenotypic characteristics. These differentiation steps are crucial for the stratification of the epidermis and the formation of the stratum corneum, ensuring the skin barrier's functions. Exposure to UV, environmental pollutants, or chemicals can lead to an overproduction of reactive species of oxygen (ROS), leading to oxidative stress. To ensure redox homeostasis and prevent damage resulting from the formation of ROS, the skin has an extensive network of antioxidant defense systems, mainly orchestrated by the nuclear factor erythroid‐2‐related factor 2 (Nrf2) pathway. Indeed, Nrf2 induces the expression of detoxification and antioxidant enzymes and suppresses inductions of pro‐inflammatory cytokine genes. In this context, Nrf2 is critical in preserving skin functions such as epidermal differentiation, regulating skin immunity, and managing environmental stresses. Besides, this pathway plays an important role in the pathogenesis of common inflammatory skin diseases such as allergic contact dermatitis, atopic dermatitis, and psoriasis. Therefore, the present review highlights the crucial role of Nrf2 in KCs for maintaining skin homeostasis and regulating skin immunity, as well as its contribution to the pathophysiology of inflammatory skin diseases. Finally, a particular emphasis will be placed on the therapeutic potential of targeting the Nrf2 pathway to alleviate symptoms of these inflammatory skin disorders.

1 April 2017 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
KHKévin Hardonnière
Kévin Hardonnière
LHLaurence Huc
Laurence Huc
OSOdile Sergent
Odile Sergent
JHJørn A. Holme
Jørn A. Holme
DLDominique Lagadic-Gossmann
Dominique Lagadic-Gossmann

11 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
DCDragos Ciocan
Dragos Ciocan
MSMADELEINE SPATZ
MADELEINE SPATZ
TNTrainel Nicolas
Trainel Nicolas
KHKévin Hardonnière
Kévin Hardonnière
SDSéverine DOMENICHINI
Séverine DOMENICHINI
ACAnne Marie Cassard-Doulcier
Anne Marie Cassard-Doulcier
Reshaping the intestinal microbiota by the ingestion of fiber, such as pectin, improves alcohol-induced liver lesions in mice by modulating bacterial metabolites, including indoles, as well as bile acids (BAs). In this context, we aimed to elucidate how oral supplementation of pectin affects BA metabolism in alcohol-challenged mice receiving feces from patients with alcoholic hepatitis. Pectin reduced alcohol liver disease. This beneficial effect correlated with lower BA levels in the plasma and liver but higher levels in the caecum, suggesting that pectin stimulated BA excretion. Pectin modified the overall BA composition, favoring an augmentation in the proportion of hydrophilic forms in the liver, plasma, and gut. This effect was linked to an imbalance between hydrophobic and hydrophilic (less toxic) BAs in the gut. Pectin induced the enrichment of intestinal bacteria harboring genes that encode BA-metabolizing enzymes. The modulation of BA content by pectin inhibited farnesoid X receptor signaling in the ileum and the subsequent upregulation of Cyp7a1 in the liver. Despite an increase in BA synthesis, pectin reduced BA serum levels by promoting their intestinal excretion. In conclusion, pectin alleviates alcohol liver disease by modifying the BA cycle through effects on the intestinal microbiota and enhanced BA excretion.

1 July 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ACAurore Collin
Aurore Collin
KHKévin Hardonnière
Kévin Hardonnière
MCMartine Chevanne
Martine Chevanne
JVJulie Vuillemin
Julie Vuillemin
NPNormand Podechard
Normand Podechard
OSOdile Sergent
Odile Sergent

1 October 2015 in Toxicology in Vitro
Verified
Journal Article
Closed access
KHKévin Hardonnière
Kévin Hardonnière
LHLaurence Huc
Laurence Huc
NPNormand Podechard
Normand Podechard
MFMorgane Fernier
Morgane Fernier
XTXavier Tekpli
Xavier Tekpli
DLDominique Lagadic-Gossmann
Dominique Lagadic-Gossmann